Interaction between oxidative stress and chemokines: Possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis

Immunobiology

Volumn 216, Issue 9, 2011, Pages 1010-1017

  Shah, Dilip ^a   Wanchu, Ajay ^b   Bhatnagar, Archana ^a  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Chemokine; Disease activity; Oxidative stress; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

CATALASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CATALASE; CHEMOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REGRESSION ANALYSIS; SUPEROXIDE DISMUTASE;

EID: 79960844662     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.04.001     Document Type: Article

References (47)

1. Al Arfaj A.S., Chowdhary A.R., Khalil N., Ali R. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus. Clin. Immunol. 2007, 124:83-89.
2. 2 or gamma irradiation is dependent on the mechanism of OH radical production. Br. J. Cancer 1988, 58:34-37.
3. Amital H., Shoenfeld Y. Autoimmunity and autoimmune diseases such as systemic lupus erythematosus. Systemic Lupus Erythematosus 2004, 3-27. Elsevier Publication, Amsterdam, The Netherlands. 4th ed. G. Lahita Robert (Ed.).
4. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31:315-324.
5. Baggiolini M. Chemokines in pathology and medicine. J. Intern. Med. 2001, 250:91-104.
6. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992, 35:630-640.
7. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 1978, 52:302-310.
8. Chapple I.L. Reactive oxygen species and antioxidants in inflammatory diseases. J. Clin. Periodontol. 1997, 24:287-296.
9. Cimen M.Y., Cimen O.B., Kacmaz M., Ozturk H.S., Yorgancioglu R., Durak I. Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis. Clin. Rheumatol. 2000, 19:275-277.
10. DeForge L.E., Preston A.M., Takeuchi E., Kenney J., Boxer L.A., Remick D.G. Regulation of interleukin 8 gene expression by oxidant stress. J. Biol. Chem. 1993, 268:25568-25576.
11. Gambhir J.K., Lali P., Jain A.K. Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin. Biochem. 1997, 30:351-355.
12. Gordon C. Long-term complications of systemic lupus erythematosus. Rheumatology (Oxford) 2002, 41:1095-1100.
13. Goronzy J.J., Weyand C.M. T-cell regulation in rheumatoid arthritis. Curr. Opin. Rheumatol. 2004, 16:212-217.
14. Haringman J.J., Ludikhuize J., Tak P.P. Chemokines in joint disease: the key to inflammation?. Ann. Rheum. Dis. 2004, 63:1186-1194.
15. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725.
16. Hoffman R.W. T cells in the pathogenesis of systemic lupus erythematosus. Clin. Immunol. 2004, 113:4-13.
17. Katschke K.J., Rottman J.B., Ruth J.H., Qin S., Wu L., LaRosa G., Ponath P., Park C.C., Pope R.M., Koch A.E. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum. 2001, 44:1022-1032.
18. Klimiuk P.A., Sierakowski S., Domyslawska I., Chwiecko J. Serum chemokines in patients with rheumatoid arthritis treated with etanercept. Rheumatol. Int. 2011, 31:457-461.
19. Koch A.E., Kunkel S.L., Harlow L.A., Johnson B., Evanoff H.L., Haines G.K., Burdick M.D., Pope R.M., Strieter R.M. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest. 1992, 90:772-779.
20. Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch. Biochem. Biophys. 1978, 186:189-195.
21. Kurien B.T., Scofield R.H. Autoimmunity and oxidatively modified autoantigens. Autoimmun. Rev. 2008, 7:567-573.
22. Kurien B.T., Scofield R.H. Lipid peroxidation in systemic lupus erythematosus. Indian J. Exp. Biol. 2006, 44:349-356.
23. Lit L.C., Wong C.K., Tam L.S., Li E.K., Lam C.W. Raised plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 2006, 65:209-215.
24. Luck H. Quantitative determination of catalase activity of biological material. Enzymologia 1954, 17:31-40.
25. Luster A.D. Chemokines - chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 1998, 338:436-445.
26. Mansour R.B., Lassoued S., Gargouri B., El Gaid A., Attia H., Fakhfakh F. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand. J. Rheumatol. 2008, 37:103-108.
27. Narumi S., Takeuchi T., Kobayashi Y., Konishi K. Serum levels of ifn-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus. Cytokine 2000, 12:1561-1565.
28. Ortona E., Margutti P., Matarrese P., Franconi F., Malorni W. Redox state, cell death and autoimmune diseases: a gender perspective. Autoimmun. Rev. 2008, 7:579-584.
29. Ozturk H.S., Cimen M.Y., Cimen O.B., Kacmaz M., Durak I. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol. Int. 1999, 19:35-37.
30. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70:158-169.
31. Perricone C., De Carolis C., Perricone R. Glutathione: a key player in autoimmunity. Autoimmun. Rev. 2009, 8:697-701.
32. Pratt A.G., Isaacs J.D., Mattey D.L. Current concepts in the pathogenesis of early rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 2009, 23:37-48.
33. Prevoo M.L., van't Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995, 38:44-48.
34. Saccani A., Saccani S., Orlando S., Sironi M., Bernasconi S., Ghezzi P., Mantovani A., Sica A. Redox regulation of chemokine receptor expression. Proc. Natl. Acad. Sci. USA 2000, 97:2761-2766.
35. Sarban S., Kocyigit A., Yazar M., Isikan U.E. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin. Biochem. 2005, 38:981-986.
36. Schuerwegh A.J., Ioan-Facsinay A., Dorjee A.L., Roos J., Bajema I.M., van der Voort E.I., Huizinga T.W., Toes R.E. Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:2586-2591.
37. Seven A., Guzel S., Aslan M., Hamuryudan V. Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clin. Biochem. 2008, 41:538-543.
38. Shah D., Kiran R., Wanchu A., Bhatnagar A. Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity. Immunol. Lett. 2010, 129:7-12.
39. Sozzani S., Bosisio D., Mantovani A., Ghezzi P. Linking stress, oxidation and the chemokine system. Eur. J. Immunol. 2005, 35:3095-3098.
40. Taysi S., Gul M., Sari R.A., Akcay F., Bakan N. Serum oxidant/antioxidant status of patients with systemic lupus erythematosus. Clin. Chem. Lab. Med. 2002, 40:684-688.
41. Tewthanom K., Janwityanuchit S., Totemchockchyakarn K., Panomvana D. Correlation of lipid peroxidation and glutathione levels with severity of systemic lupus erythematosus: a pilot study from single center. J. Pharm. Pharm. Sci. 2008, 11:30-34.
42. Turgay M., Durak I., Erten S., Ertugrul E., Devrim E., Avci A., Turgay F. Oxidative stress and antioxidant parameters in a Turkish group of patients with active and inactive systemic lupus erythematosus. APLAR J. Rheumatol. 2007, 10:101-106.
43. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
44. Vila L.M., Molina M.J., Mayor A.M., Cruz J.J., Rios-Olivares E., Rios Z. Association of serum MIP-1alpha, MIP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus. Clin. Rheumatol. 2007, 26:718-722.
45. Ye D.Q., Yang S.G., Li X.P., Hu Y.S., Yin J., Zhang G.Q., Liu H.H., Wang Q., Zhang K.C., Dong M.X., Zhang X.J. Polymorphisms in the promoter region of RANTES in Han Chinese and their relationship with systemic lupus erythematosus. Arch. Dermatol. Res. 2005, 297:108-113.
46. Zhang Q., Ye D.Q., Chen G.P., Zheng Y. Oxidative protein damage and antioxidant status in systemic lupus erythematosus. Clin. Exp. Dermatol 2009.
47. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.